Key result
High baseline TMTV predicts ~304% higher mortality in double expression diffuse large B-cell lymphoma.
Why the study?
The study was conducted to explore the value of baseline PET/CT parameters for predicting prognosis in patients with double expression lymphoma.
Population
118 patients diagnosed with DLBCL at two independent medical centers
Comparison
Baseline PET/CT metabolic parameters (SUVmax, TMTV, TLG) for predicting OS
Design
Two-center retrospective cohort study
Authors
Loading...
Baseline PET/CT parameters may stratify DEL prognosis; leaves open incremental value beyond IPI in prospective validation.
Cohort (n=118)
Yes
Hazard Ratio: 4.042 (95% CI 1.445–11.312)
p-value: p=0.008
Total metabolic tumor volume (TMTV) and ECOG performance status are independent predictors of overall survival in patients with double expression lymphoma, and their combination provides accurate prognostic predictions.
Zhao et al. (2023) conducted a cohort in Double expression diffuse large B-cell lymphoma (DEL) (n=118). High total metabolic tumor volume (TMTV ≥ 230.9 cm3) vs. Low TMTV (< 230.9 cm3) was evaluated on Overall survival (OS) (HR 4.042, 95% CI 1.445-11.312, p=0.008). High baseline total metabolic tumor volume (TMTV > 230.9 cm3) independently predicted worse overall survival (HR 4.042) in patients with double expression diffuse large B-cell lymphoma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: